BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18495196)

  • 1. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
    Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
    Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
    Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
    PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
    Zhang W; Du J; Yu K; Wang T; Yong X; Yu XF
    J Virol; 2010 Dec; 84(24):12903-13. PubMed ID: 20926562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
    Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
    J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
    Pery E; Rajendran KS; Brazier AJ; Gabuzda D
    J Virol; 2009 Mar; 83(5):2374-81. PubMed ID: 19109396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
    Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
    PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
    Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
    J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
    Wang T; Tian C; Zhang W; Sarkis PT; Yu XF
    J Mol Biol; 2008 Jan; 375(4):1098-112. PubMed ID: 18067920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity.
    Wang Y; Kinlock BL; Shao Q; Turner TM; Liu B
    Retrovirology; 2014 Oct; 11():89. PubMed ID: 25304135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
    Burnett A; Spearman P
    J Virol; 2007 May; 81(10):5000-13. PubMed ID: 17344295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.
    Khan MA; Goila-Gaur R; Opi S; Miyagi E; Takeuchi H; Kao S; Strebel K
    Retrovirology; 2007 Jul; 4():48. PubMed ID: 17631688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.
    Schäfer A; Bogerd HP; Cullen BR
    Virology; 2004 Oct; 328(2):163-8. PubMed ID: 15464836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
    Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
    J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.
    Tian C; Wang T; Zhang W; Yu XF
    Nucleic Acids Res; 2007; 35(21):7288-302. PubMed ID: 17959647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1.
    McDonnell MM; Crawford KHD; Dingens AS; Bloom JD; Emerman M
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
    Khan MA; Goila-Gaur R; Kao S; Miyagi E; Walker RC; Strebel K
    Retrovirology; 2009 Nov; 6():99. PubMed ID: 19886996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
    Li J; Chen Y; Li M; Carpenter MA; McDougle RM; Luengas EM; Macdonald PJ; Harris RS; Mueller JD
    J Mol Biol; 2014 Mar; 426(6):1296-307. PubMed ID: 24361275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.